M4MM
Vireo Growth Reports Q2 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported GAAP revenue of $209.3 million for the three months ended June 30, 2026, up 335% year-over-year from $48.1 million in Q2 2025, driven by the Eaze, Hawthorne Gardening Company, ...
Senate Votes to Extend Hemp THC Ban Timeline
WASHINGTON – The U.S. Senate voted to table a bipartisan amendment that would have kept a federal hemp THC ban on schedule for November. By a 61-32 margin, the chamber defeated a proposal from Sen. ...
Puerto Rico Governor Orders Psychedelics Research
SAN JUAN – Puerto Rico’s governor has directed the territory’s health department to examine the practical steps needed to advance clinical research into emerging therapies, including certain psychedelic compounds. The move positions a commonwealth to ...
Trulieve Earns Spot on TIME’s America’s Best Companies 2026 List
TALLAHASSEE – Trulieve Cannabis Corp. received recognition from TIME magazine as one of America's Best Companies for 2026. The Florida-based medical Cannabis operator is one of only two Cannabis companies to appear on the list, ...
Nepal’s Gandaki Province Breaks Ground on Regulated Cannabis Cultivation
KATHMANDU – The Gandaki Province Assembly in Nepal has passed landmark legislation legalizing the cultivation of Cannabis for medicinal and industrial purposes. This makes the province a pioneer in the country, setting the stage for ...
Rhode Island Moves to Restart Cannabis Retail Licensing
PROVIDENCE – Rhode Island officials are taking steps to revive a stalled process for issuing new retail Cannabis licenses. A federal judge blocked the effort earlier this year over concerns about state residency rules. Lawmakers ...
Curaleaf Opens Free CPD Training Portal for UK Medical Cannabis Prescribers
LONDON – Medical Cannabis has been legally prescribable in the UK since 2018. The endocannabinoid system, the biological mechanism at the core of how cannabinoid therapies work, still gets barely a mention in most British ...
Vireo Growth Reports Q2 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported GAAP revenue of $209.3 million for the three months ended June 30, 2026, up 335% year-over-year from $48.1 million in Q2 2025, driven by the Eaze, Hawthorne Gardening Company, ...
Senate Votes to Extend Hemp THC Ban Timeline
WASHINGTON – The U.S. Senate voted to table a bipartisan amendment that would have kept a federal hemp THC ban on schedule for November. By a 61-32 margin, the chamber defeated a proposal from Sen. ...
Puerto Rico Governor Orders Psychedelics Research
SAN JUAN – Puerto Rico’s governor has directed the territory’s health department to examine the practical steps needed to advance clinical research into emerging therapies, including certain psychedelic compounds. The move positions a commonwealth to ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors wrapped up 2025 on a high note, with federal policy breakthroughs and corporate maneuvers signaling sustained growth potential across Cannabis & Psychedelics. Over the past two weeks, President Trump's ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Michigan Senate Tightens Controls on Intoxicating Hemp Derivatives
LANSING – In a bipartisan push to close regulatory gaps, the Michigan Senate approved a package of bills that would classify most high-potency hemp-derived THC items as Cannabis, folding them into the state's established Cannabis ...
Trulieve Secures $140M in Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up a $140 million private placement of 10.5% senior secured notes, tapping into robust investor appetite to fuel its operational push. The deal, upsized from initial plans, comes just ...
🚨🚨 BREAKING: TRUMP RESCHEDULES CANNABIS 🚨🚨
WASHINGTON, D.C. –After months of speculation, President Trump Issues Executive Order Directing Federal Rescheduling of Cannabis to Schedule III President Donald Trump has signed an executive order directing federal agencies to complete the rescheduling of ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
Organigram Reports Q4 2025 Financial and Full Fiscal Year Results
TORONTO – Organigram Global Inc. released its record Q4 and fiscal 2025 results, showing substantial gains in revenue and profitability metrics despite a quarterly net loss tied to one-time charges. For the fourth quarter, gross ...
The Supreme Court Declines to Resolve Federal Cannabis Prohibition—And the Silence Speaks Volumes
WASHINGTON, D.C. – In its December Orders List, the U.S. Supreme Court declined to hear a case that many hoped would finally force a reckoning between federal Cannabis prohibition and state-legal markets. By declining review, ...
Canopy Growth Acquires MTL Cannabis in Bid to Ramp Up Medical Sales
SMITHS FALLS – Canopy Growth Corp., a major player in the Canadian Cannabis sector, has signed a definitive agreement to purchase MTL Cannabis Corp. in a cash-and-stock transaction worth about $125 million on a fully ...
Trump Sets Plans for Cannabis Reclassification Executive Order
WASHINGTON – President Donald Trump is set to direct federal agencies to reclassify Cannabis from its current Schedule I status to Schedule III under the Controlled Substances Act, a step that would align federal oversight ...
Mid-Cap Cannabis Operators Face Liquidity Pressures Despite Solid Leverage, Viridian Report Finds
LOS ANGELES – Public Cannabis companies with $25-100 million market values are navigating a patchwork of financial strengths and vulnerabilities, according to the latest Weekly Credit Report from Viridian Capital Advisors. It tracks eight U.S.-based ...
Ascend Wellness Partners with Cannabis Advocate for New Dispensary in New Jersey
NEW YORK – Ascend Wellness Holdings Inc. disclosed a partnership with Mister Jones LLC and industry advocate Lerone Jones to launch a retail dispensary in Little Falls, NJ. The arrangement, one of the initial deals ...
Grown Rogue Claims Ground in Minnesota
MINNEAPOLIS – Grown Rogue International Inc., a Сannabis MSO focused on premium flower, has signed a long-term lease for a 109,000-square-foot facility in Fridley, just north of Minneapolis, positioning the company to produce for the ...
